BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8806879)

  • 1. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
    Steinmetz KL; Klaunig JE
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of Triamterene (CAS No. 396-01-0) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Dec; 420():1-367. PubMed ID: 12616291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
    Moser GJ; Wolf DC; Goldsworthy TL
    Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Polybrominated Biphenyls (CAS No. 67774-32-7)(Firemaster FF-1(R)) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 398():1-235. PubMed ID: 12637961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis.
    Drucker C; Parzefall W; Teufelhofer O; Grusch M; Ellinger A; Schulte-Hermann R; Grasl-Kraupp B
    Carcinogenesis; 2006 Jan; 27(1):152-61. PubMed ID: 16081514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression.
    Dragan Y; Teeguarden J; Campbell H; Hsia S; Pitot H
    Cancer Lett; 1995 Jun; 93(1):73-83. PubMed ID: 7600545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.
    Lee TY; Kim KT; Han SY
    Korean J Hepatol; 2007 Mar; 13(1):70-80. PubMed ID: 17380077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion.
    Miller RT; Cattley RC; Marsman DS; Lyght O; Popp JA
    Carcinogenesis; 1995 Jan; 16(1):77-82. PubMed ID: 7530605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis.
    Burr AW; Toole K; Mathew J; Hines JE; Chapman C; Burt AD
    J Pathol; 1996 Jul; 179(3):276-82. PubMed ID: 8774483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-alpha expression in rat experimental hepatocarcinogenesis.
    Pérez-Tomás R; Mayol X; Culleré X; Díaz Ruiz C; Domingo J
    Histol Histopathol; 1992 Jul; 7(3):457-62. PubMed ID: 1504466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
    Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC
    Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.